New Key Statistics Module, Z-Score and F-Score
NAS:HBIO Key Ratios
| Market Cap $ M | 125.51 |
| Enterprise Value $ M | 164.36 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 82.57 |
| Forward PE Ratio | -- |
| Price/Book | 1.82 |
| Price/Sales | 1.12 |
| Price/Free Cash Flow | 11.37 |
| Price/Owner Earnings | 24.47 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 106.00 |
| EPS (TTM) $ | -0.20 |
| Beneish M-Score | -3.33 |
| 10-y EBITDA Growth Rate % | -1.80 |
| 5-y EBITDA Growth Rate % | -12.40 |
| y-y EBITDA Growth Rate % | -77.30 |
| EV-to-EBIT | -33.69 |
| EV-to-EBITDA | 75.43 |
| PEG | -- |
| Shares Outstanding M | 43.43 |
| Net Margin (%) | -8.18 |
| Operating Margin % | -2.00 |
| Pre-tax Margin (%) | -7.72 |
| Quick Ratio | 0.94 |
| Current Ratio | 1.88 |
| ROA % (ttm) | -6.25 |
| ROE % (ttm) | -11.93 |
| ROIC % (ttm) | -1.75 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.49 |
HBIO Number of Guru Trades
HBIO Volume of Guru Trades
Gurus Latest Trades with NAS:HBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Harvard Bioscience Inc Insider Transactions
No Available Data
News about NAS:HBIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers